Nicotinic agonist and antagonist effects on memory

Drug Development Research

Volumn 38, Issue 3-4, 1996, Pages 188-195

  Levin, Edward D ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Nicotine; Nicotinic; Radial arm maze; Working memory

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

AGING; AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CIGARETTE SMOKING; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HIPPOCAMPUS; HUMAN; INTRACEREBRAL DRUG ADMINISTRATION; MAZE TEST; MEMORY; NONHUMAN; RAT; SCHIZOPHRENIA; WORKING MEMORY;

EID: 0030460689     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199607/08)38:3/4<188::AID-DDR7>3.0.CO;2-I     Document Type: Article

References (67)

1. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R (1992): Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatr 32:607-616.
2. Adler LE, Hoffer LD, Wiser A, Freedman R (1993a): Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatr 150:1856-1861.
3. Andrews JS, Jansen JHM, Linders S, Princen A (1994): Effects of disrupting the cholinergic system on short-term spatial memory in rats. Psychopharmacology 115:485-494
4. Arendash GW, Sanberg PR, Sengstock GJ (1995a): Nicotine enhances the learning and memory of aged rats. Pharmacol Biochem Behav 52:517-523.
5. Arendash GW, Sengstock GJ, Sanberg PR, Kem WR (1995b): Improved learning and memory in aged rats with chronic admin-istration of the nicotinic receptor agonist GTS-21. Brain Res 674:252-259.
6. Brioni JD, Arneric SP (1993): Nicotinic receptor agonists facilitate retention of avoidance training - Participation of dopaminergic mechanisms. Behav Neural Biol 59:57-62.
7. Brucato FH, Levin ED, Rose JE, Swartzwelder HS (1994): Interocerebroventricular nicotine and mecamylamine alters radial-arm maze performance in rats. Drug Dev Res 31:18-23.
8. Buccafusco JJ, Jackson WJ (1991): Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol Aging 12:233-238.
9. Buccafusco JJ, Jackson WJ, Terry AV, Marsh KC, Decker MW, Arneric SP (1995): Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: A novel cholinergic channel activator for memory enhancement. Psychopharmacology 120:256-266.
10. Curzon P, Brioni JD, Decker MW (1996): Effect of intraventricular injections of dihydro-beta-erythroidine (DHβE) on spatial memory in the rat. Brain Res 714:185-191.
11. Decker MW, Majchrzak MJ (1992): Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotine cholinergic antagonist, on spatial memory in rats. Psychopharmacology 107:530-534.
12. Decker MW, Majchrzak MJ, Anderson DJ (1992): Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res 572:281-285.
13. Decker MW, Majchrzak MJ, Arneric SP (1993): Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol Biochem Behav 45:571-576.
14. Decker MW, Curzon P, Brioni JD, Arneric SP (1994): Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Eur J Pharmacol 261:217-222.
15. Decker MW, Brioni JD, Bannon AW, Arneric SP (1995): Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics - Minireview. Life Sci 56:545-570.
16. Dunnett SB, Martel FL (1990): Proactive interference effects on short-term memory in rats: 1. Basic parameters and drug effects. Behav Neurosci. 104:655-665.
17. Freedman R, Hall M, Adler LE, Leonard S (1995): Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatr 38:22-33.
18. Granon S, Poucet B, Thinusblanc C, Changeux JP, Vidal C (1995): Nicotinic and muscarinic receptors in the rat prefrontal cortex: Differential roles in working memory, response selection and effortful processing. Psychopharmacology 119:139-144.
19. Grigoryan GA, Mitchell SN, Hodges H, Sinden JD, Gray JA (1994): Are the cognitive-enhancing effects of nicotine in the rat with lesions to the forebrain cholinergic projection system mediated by an interaction with the noradrenergic system? Pharmacol Biochem Behav 49:511-521.
20. Grigoryan G, Hodges H, Mitchell S, Sinden JD, Gray JA (1996): 6-OHDA lesions of the nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system: Effects of nicotine administration on learning and memory in the water maze. Neurobiol Learn Memory 65: 135-153.
21. Hiramatsu M, Satoh H, Kameyama T, Nabeshima T (1994): Nootropic effect of nicotine on carbon monoxide (CO)-induced delayed amnesia in mice. Psychopharmacology 116:33-39.
22. Jackson WJ, Elrod K, Buccafusco JJ (1989): Delayed matching-to-sample in monkeys as a model for learning and memory deficits: Role of brain nicotinic receptors. In Meyer EM, Simplkins JW, Yamamoto J (eds): Novel Approaches to the Treatment of Alzheimer's Disease. New York: Plenum Publishing Corporation, pp 39-52.
23. Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992): Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485-494.
24. Kim J, Levin E (1996): Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: Effects on spatial working memory in rats. Brain Res 725:231-240.
25. Levin ED (1988): Psychopharmacological effects in the radial-arm maze. Neurosci Biobehav Rev 12:169-175.
26. Levin ED (1992): Nicotinic systems and cognitive function. Psychopharmacology 108:417-431.
27. Levin ED (1995): Interactive effects of nicotinic and muscarinic agonists with the dopaminergic agonist pergolide on rats in the radial-arm maze. Pharmacol Biochem Behav 52:837-840.
28. Levin ED, Eisner B (1994). Nicotine interactions with D1 and D2 agonists: Effects on working memory function. Drug Dev Res 31:32-37.
29. Levin ED, Rose JE (1990): Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats. Behav Pharmacol 1:511-520.
30. Levin ED, Rose JE (1991): Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. Brain Res Bull 27:125-128.
31. 2 interactions with nicotinic and muscarinic systems. In Levin ED, Decker MW, Butcher LL (eds): Neurotransmitter Interactions and Cognitive Function. Boston: Berkhäuser, pp 144-158.
32. Levin ED, Rose JE (1995): Acute and chronic nicotinic interactions with dopamine systems and working memory performance. In Lajtha A, Abood L (eds): Functional Diversity of Interacting Receptors. The New York: New York Academy of Sciences, pp 218-221.
33. Levin ED, Torry D (1995): Nicotine effects on memory performance. In Clarke PBS, Quik M, Thurau K, Adlkofer F (eds): International Symposium on Nicotine: The Effects of Nicotine on Biological Systems II. Boston: Birkhäuser, pp 329-336.
34. Levin ED, Torry D (1996): Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology 123:88-97.
35. Levin ED, Castonguay M, Ellison CD (1987): Effects of the nicotinic receptor blocker, mecamylamine, on radial arm maze performance in rats. Behav Neural Biol. 48:206-212.
36. 2 agonist, LY 171555. Pharmacol Biochem Behav 33:919-922.
37. Levin ED, Lee C, Rose JE, Reyes A, Ellison G, Jarvik M, Gritz E (1990): Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav Neural Biol 53:269-276.
38. Levin ED, Briggs SJ, Christopher NC, Rose JE (1992): Persistence of chronic nicotine-induced cognitive facilitation. Behav Neural Biol 58:152-158.
39. Levin ED, Briggs SJ, Christopher NC, Rose JE (1993a): Chronic nicotinic stimulation and blockade effects on working memory. Behav Pharmacol 4:179-182.
40. Levin ED, Christopher NC, Briggs SJ, Rose JE (1993b): Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Cog Brain Res 1:137-143.
41. Levin ED, Briggs SJ, Christopher NC, Auman JT (1994): Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra. Brain Res 657:165-170.
42. Levin ED, Rose JE, Abood L (1995): Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze. Pharmacol Biochem Behav 51:369-373.
43. Levin E, Kim P, Meray R (1996a): Chronic nicotine effects on working and reference memory in the 16-arm radial maze: Interactions with D1 agonist and antagonist drugs. Psychopharmacology 127:25-30.
44. Levin E, Wilson W, Rose J, McEvoy J (1996b): Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology (in press).
45. Levin ED, Conners CK, Sparrow E, Hinton S, Meek W, Rose JE, Ernhardt D, March J (1996c): Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 123:55-63.
46. McEvoy JP, Freudenreich O, Levin ED, Rose JE (1995): Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 119:124-126.
47. McGurk SR, Levin ED, Butcher LL (1989a): Nicotinic-dopaminergic relationships and radial-arm maze performance in rats. Behav Neural Biol 52:78-86.
48. 2 dopaminergic drugs. Psychopharmacology 99:371-373.
49. Meguro K, Yamaguchi S, Arai H, Nakagawa T, Doi C, Yamada M, Ikarashi Y, Maruyama Y, Sasaki H (1994): Nicotine improves cognitive disturbance in senescence-accelerated mice. Pharmacol Biochem Behav 49:769-772.
50. Moran PM (1993): Differential effects of scopolamine and mecamylamine on working and reference memory in the rat. Pharmacol Biochem Behav 45:533-538.
51. Muir JL, Everitt BJ, Robbins TW (1995): Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology 118:82-92.
52. Newhouse PA, Sunderland T, Thompson K, Tariot PN, Weingartner H, Mueller ER, Cohen RM, Murphy DL (1986): Intravenous nicotine in a patient with Alzheimer's disease. Am J Psychiatr 143:1494-1495.
53. Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL (1988): Intravenous nicotine in Alzheimer's disease: A pilot study. Psychopharmacology 95: 171-175.
54. Newhouse P, Potter A, Corwin J (1996): Acute administration of the cholinergic channel activator ABT-418 improves learning in Alzheimer's disease. Washington, DC: Society for Research on Nicotine and Tobacco, poster A39.
55. Nitta A, Katono Y, Itoh A, Hasegawa T, Nabeshima T (1994): Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system. Pharmacol Biochem Behav 49: 807-812.
56. Ochoa ELM, Chattopadhyay A, McNamee MG (1989): Desensitization of the nicotinic acetylcholine receptor: Molecular mechanisms and effect of modulators. Cell Mol Neurobiol 9:141-178.
57. Ohno M, Yamamoto T, Watanabe S (1993): Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats. Pharmacol Biochem Behav 45:89-93.
58. Oliverio A (1966): Effects of mecamylamine on avoidance conditioning and maze learning of mice. J Pharmacol Exp Ther 154: 350-356.
59. Ridley RM, Murray TK, Johnson JA, Baker HF (1986): Learning impairment following lesion of basal nucleus of Meynert in the marmoset: Modification by cholinergic drugs. Brain Res 376: 108-116.
60. Riekkinen PJ, Sirviö J, Aaltonen M, Riekkinen P (1990): Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning. Pharmacol Biochem Behav 37:405-410.
61. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989): The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type. Br J Psychiatr 154:797-800.
62. Sahakian BJ, Jones GMM (1991): The effects of nicotine on attention, information processing, and working memory in patients with dementia of the Alzheimer type. In Adlkofer F, Thruau K (eds): Effects of Nicotine on Biological Systems. Basel: Birkhauser Verlag, pp 623-230.
63. Socci DJ, Sanberg PR, Arendash GW (1995): Nicotine enhances Morris water maze performance of young and aged rats. Neurobiol Aging 16:857-860.
64. Terry AV, Buccafusco JJ, Jackson WJ (1993): Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. Pharmacol Biochem Behav 45:925-929.
65. Widzowski DV, Cregan E, Bialobok P (1994): Effects of nicotinic agonists and antagonists on spatial working memory in normal adult and aged rats. Drug Dev Res 31:24-31.
66. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, Mcfalls E, Kovera C, Mccarten JR (1995): Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-514.
67. Woodruff-Pak DS, Li YT, Kem WR (1994): A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Res 645:309-317.